New Jersey

New Jersey remains the definitive global life sciences hub, often recognized as the "Medicine Chest of the World" due to its unparalleled density of expertise.

As of 2026, the state hosts the highest concentration of scientists and engineers per square mile in the US, driving a robust biopharmaceutical manufacturing sector that accounts for nearly 8% of the state's GDP. This vibrant ecosystem is anchored by world-renowned pharmaceutical headquarters, including industry titans like Johnson & Johnson, Merck and Bristol Myers Squibb.

Beyond traditional pharma, New Jersey has emerged as a leader in cell and gene therapy, with approximately 40% of all such therapies in global development passing through the region.

The state's biotechnology landscape is further bolstered by a 27% increase in specialized lab space and a thriving network of startup incubators like SciTech Scity and HELIX.

In the medical device sector, New Jersey ranks among the top in the nation, home to giants such as Becton Dickinson and Stryker who pioneer breakthroughs in healthcare innovation and neurotechnology.

Academic research is a cornerstone of this progress, fueled by elite institutions like Princeton and Rutgers that bridge the gap between translational medicine and commercial success.

Strategically located between New York City and Philadelphia, the state offers a premier life sciences workforce and a sophisticated supply chain for clinical trials and drug discovery.

From biotech startups to multinational corporations, New Jersey provides the critical infrastructure and venture capital access necessary to scale life-saving technologies from the bench to the bedside.